Literature DB >> 3257290

Measurement of in vivo HGPRT-deficient mutant cell frequency using a modified method for cloning human peripheral blood T-lymphocytes.

M Hakoda1, M Akiyama, S Kyoizumi, K Kobuke, A A Awa, M Yamakido.   

Abstract

Approximately 80% of human peripheral blood T-lymphocytes could be cloned in the presence of crude interleukin-2, phytohemagglutinin, and X-irradiated autologous lymphocytes and Raji B-cells. This modified cloning method was used to measure the in vivo frequency of HGPRT-deficient mutant T-lymphocytes. Repeated experiments using blood from the same individuals revealed that the frequency of mutant cells was almost constant for each individual even though the cloning efficiency of lymphocytes varied somewhat from experiment to experiment. Approximately 80% of both wild-type unselected and 6-thioguanine-resistant colonies had helper/inducer and about 20% had suppressor/cytotoxic T-lymphocyte markers. No difference was observed in the distribution of lymphocyte subsets in relation to colony type.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3257290     DOI: 10.1016/0027-5107(88)90153-4

Source DB:  PubMed          Journal:  Mutat Res        ISSN: 0027-5107            Impact factor:   2.433


  6 in total

1.  Selection against blood cells deficient in hypoxanthine phosphoribosyltransferase (HPRT) in Lesch-Nyhan heterozygotes occurs at the level of multipotent stem cells.

Authors:  M Hakoda; Y Hirai; M Akiyama; H Yamanaka; C Terai; N Kamatani; S Kashiwazaki
Journal:  Hum Genet       Date:  1995-12       Impact factor: 4.132

2.  Paradoxical expression of adenosine deaminase in T cells cultured from a patient with adenosine deaminase deficiency and combine immunodeficiency.

Authors:  F X Arredondo-Vega; J Kurtzberg; S Chaffee; I Santisteban; E Reisner; M S Povey; M S Hershfield
Journal:  J Clin Invest       Date:  1990-08       Impact factor: 14.808

3.  Cloning of phenotypically different human lymphocytes originating from a single stem cell.

Authors:  M Hakoda; Y Hirai; H Shimba; Y Kusunoki; S Kyoizumi; Y Kodama; M Akiyama
Journal:  J Exp Med       Date:  1989-04-01       Impact factor: 14.307

4.  Mutagenesis after cancer therapy.

Authors:  K T Kelsey; M Caggana; P M Mauch; C N Coleman; J R Clark; H L Liber
Journal:  Environ Health Perspect       Date:  1993-10       Impact factor: 9.031

5.  Spontaneous loss and alteration of antigen receptor expression in mature CD4+ T cells.

Authors:  S Kyoizumi; M Akiyama; Y Hirai; Y Kusunoki; K Tanabe; S Umeki
Journal:  J Exp Med       Date:  1990-06-01       Impact factor: 14.307

6.  Somatic mutation in peripheral lymphocytes of former workers at the Okunojima poison gas factory.

Authors:  J Yanagida; S Hozawa; S Ishioka; H Maeda; K Takahashi; T Oyama; M Takaishi; M Hakoda; M Akiyama; M Yamakido
Journal:  Jpn J Cancer Res       Date:  1988-12
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.